|
1
|
Aziz I and Simrén M: The overlap between
irritable bowel syndrome and organic gastrointestinal diseases.
Lancet Gastroenterol Hepatol. 6:139–148. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bao CH, Wang CY, Li GN, Yan YL, Wang D,
Jin XM, Wu LY, Liu HR, Wang XM, Shi Z and Wu HG: Effect of mild
moxibustion on intestinal microbiota and NLRP6 inflammasome
signaling in rats with post-inflammatory irritable bowel syndrome.
World J Gastroenterol. 25:4696–4714. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Black CJ and Ford AC: Global burden of
irritable bowel syndrome: Trends, predictions and risk factors. Nat
Rev Gastroenterol Hepatol. 17:473–486. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Klem F, Wadhwa A, Prokop LJ, Sundt WJ,
Farrugia G, Camilleri M, Singh S and Grover M: Prevalence, risk
factors, and outcomes of irritable bowel syndrome after infectious
enteritis: A systematic review and meta-analysis. Gastroenterology.
152:1042–1054.e1. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tian Z, Zhuang X, Luo M, Yin W and Xiong
L: The propionic acid and butyric acid in serum but not in feces
are increased in patients with diarrhea-predominant irritable bowel
syndrome. BMC Gastroenterol. 20:732020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu ZC, Cen YX, Wu BH, Wei C, Xiong F, Li
DF, Liu TT, Luo MH, Guo LL, Li YX, et al: Berberine prevents
stress-induced gut inflammation and visceral hypersensitivity and
reduces intestinal motility in rats. World J Gastroenterol.
25:3956–3971. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scuderi SA, Casili G, Lanza M, Filippone
A, Paterniti I, Esposito E and Campolo M: Modulation of NLRP3
inflammasome attenuated inflammatory response associated to
diarrhea-predominant irritable bowel syndrome. Biomedicines.
8:5192020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zeng L, Li K, Wei H, Hu J, Jiao L, Yu S
and Xiong Y: A Novel EphA2 inhibitor exerts beneficial effects in
PI–IBS in vivo and in vitro models via Nrf2 and NF-κB signaling
pathways. Front Pharmacol. 9:2722018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gu QY, Zhang J and Feng YC: Role of NLRP3
inflammasome in Bifidobacterium longum-regulated visceral
hypersensitivity of postinfectious irritable bowel syndrome. Artif
Cells Nanomed Biotechnol. 44:1933–1937. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liao L, Schneider KM, Galvez EJC, Frissen
M, Marschall HU, Su H, Hatting M, Wahlström A, Haybaeck J, Puchas
P, et al: Intestinal dysbiosis augments liver disease progression
via NLRP3 in a murine model of primary sclerosing cholangitis. Gut.
68:1477–1492. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He Y, Hara H and Núñez G: Mechanism and
regulation of NLRP3 inflammasome activation. Trends Biochem Sci.
41:1012–1021. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hennig P, Garstkiewicz M, Grossi S, Di
Filippo M, French LE and Beer HD: The Crosstalk between Nrf2 and
Inflammasomes. Int J Mol Sci. 19:5622018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arioz BI, Tastan B, Tarakcioglu E, Tufekci
KU, Olcum M, Ersoy N, Bagriyanik A, Genc K and Genc S: Melatonin
attenuates LPS-Induced acute depressive-like behaviors and
microglial NLRP3 Inflammasome activation through the SIRT1/Nrf2
pathway. Front Immunol. 10:15112019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang Y, Vong CT, Zeng S, Gao C, Chen Z, Fu
C, Wang S, Zou L, Wang A and Wang Y: Tracking evidences of Coptis
chinensis for the treatment of inflammatory bowel disease from
pharmacological, pharmacokinetic to clinical studies. J
Ethnopharmacol. 268:1135732021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song D, Hao J and Fan D: Biological
properties and clinical applications of berberine. Front Med.
14:564–582. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu J, Luo Y, Deng D, Su S, Li S, Xiang L,
Hu Y, Wang P and Meng X: Coptisine from Coptis chinensis exerts
diverse beneficial properties: A concise review. J Cell Mol Med.
23:7946–7960. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu J, Luo Y, Jiang Q, Li S, Huang W, Xiang
L, Liu D, Hu Y, Wang P, Lu X, et al: Coptisine from Coptis
chinensis blocks NLRP3 inflammasome activation by inhibiting
caspase-1. Pharmacol Res. 147:1043482019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Adriani A, Ribaldone DG, Astegiano M,
Durazzo M, Saracco GM and Pellicano R: Irritable bowel syndrome:
The clinical approach. Panminerva Med. 60:213–222. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ghoshal UC and Gwee KA: Post-infectious
IBS, tropical sprue and small intestinal bacterial overgrowth: The
missing link. Nat Rev Gastroenterol Hepatol. 14:435–441. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiong Y, Li KX, Wei H, Jiao L, Yu SY and
Zeng L: Eph/ephrin signalling serves a bidirectional role in
lipopolysaccharide-induced intestinal injury. Mol Med Rep.
18:2171–2181. 2018.PubMed/NCBI
|
|
21
|
Forman HJ and Zhang H: Targeting oxidative
stress in disease: Promise and limitations of antioxidant therapy.
Nat Rev Drug Discov. 20:689–709. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Puentes-Pardo JD, Moreno-SanJuan S, Carazo
Á and León J: Heme Oxygenase-1 in gastrointestinal tract health and
disease. Antioxidants (Basel). 9:12142020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feng M, Kong SZ, Wang ZX, He K, Zou ZY, Hu
YR, Ma H, Li XG and Ye XL: The protective effect of coptisine on
experimental atherosclerosis ApoE−/− mice is mediated by
MAPK/NF-κB-dependent pathway. Biomed Pharmacother. 93:721–729.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu YR, Ma H, Zou ZY, He K, Xiao YB, Wang
Y, Feng M, Ye XL and Li XG: Activation of Akt and JNK/Nrf2/NQO1
pathway contributes to the protective effect of coptisine against
AAPH-induced oxidative stress. Biomed Pharmacother. 85:313–322.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He K, Ye X, Wu H, Wang Y, Zou Z, Ning N,
Hu Y, Chen B, Fang X and Li X: The safety and
anti-hypercholesterolemic effect of coptisine in Syrian golden
hamsters. Lipids. 50:185–194. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mangan MSJ, Olhava EJ, Roush WR, Seidel
HM, Glick GD and Latz E: Targeting the NLRP3 inflammasome in
inflammatory diseases. Nat Rev Drug Discov. 17:588–606. 2018.
View Article : Google Scholar : PubMed/NCBI
|
